Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report From the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1961
Full Text
Open PDFAbstract
Available in full text
Date
March 9, 2010
Authors
Publisher
American Association for Cancer Research (AACR)